(Q51465582)

English

Interaction between a commercially available St. John's wort product (Movina) and atorvastatin in patients with hypercholesterolemia.

scientific article published on 15 August 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17701167

Interaction between a commercially available St. John's wort product (Movina) and atorvastatin in patients with hypercholesterolemia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17701167

hypercholesterolemia

0 references

Robert Eggertsen

object named as

R Eggertsen

3

0 references

author name string

L Andrén

1

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17701167

A Andreasson

2

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17701167

publication date

15 August 2007

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17701167

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17701167

63

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17701167

10

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17701167

913-916

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17701167

https://scigraph.springernature.com/pub.10.1007/s00228-007-0345-x

0 references

Use and expenditure on complementary medicine in England: a population based survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial— Lipid Lowering Arm (ASCOT-LLA)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute heart transplant rejection due to Saint John's wort

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of St John's wort with conventional drugs: systematic review of clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of P-glycoprotein in statin drug interactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John's wort ( Hypericum perforatum ).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indinavir concentrations and St John's wort.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17701167

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00228-007-0345-X

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17701167

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17701167

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51465582&oldid=1399540117"